Cargando…
Retraction: Rapamycin Inhibits Proliferation of Hemangioma Endothelial Cells by Reducing HIF-1-Dependent Expression of VEGF
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Public Library of Science
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7373264/ https://www.ncbi.nlm.nih.gov/pubmed/32692750 http://dx.doi.org/10.1371/journal.pone.0234141 |
Ejemplares similares
-
Retraction: Inhibition of microRNA-218 reduces HIF-1α by targeting on Robo1 in mice aortic endothelial cells under intermittent hypoxia
por: Liu, Kai-Xiong, et al.
Publicado: (2023) -
The Inhibitive Effect of sh-HIF1A-AS2 on the Proliferation, Invasion, and Pathological Damage of Breast Cancer via Targeting miR-548c-3p Through Regulating HIF-1α/VEGF Pathway in vitro and vivo [Retraction]
Publicado: (2021) -
Retraction: Rapamycin-loaded nanoparticles for inhibition of neointimal hyperplasia in experimental vein grafts
por: Zou, Junjie, et al.
Publicado: (2012) -
Retracted: Long Noncoding RNA DSCAM-AS1 Facilitates Proliferation and Migration of Hemangioma Endothelial Cells by Targeting miR-411-5p/TPD52 Axis
por: International, BioMed Research
Publicado: (2023) -
Arnebin-1 promotes angiogenesis by inducing eNOS, VEGF and HIF-1α expression through the PI3K-dependent pathway
por: Zeng, Zhi, et al.
Publicado: (2023)